Liquidia : Announces Chief Executive Officer Transition - Form 8-K

Liquidia Corporation Announces Chief Executive Officer Transition


MORRISVILLE, N.C., January 3, 2022 - Liquidia Corporation today announced Dr. Roger Jeffs has been appointed... | January 4, 2022

Related Keywords

Delaware ,United States ,Roger Jeffs ,Stephen Bloch ,Paul Manning ,Jason Adair ,Burroughs Wellcome Co ,Liquidia Technologies Inc ,Company Board Of Directors ,York Heart Association ,Dova Pharmaceuticals ,United Therapeutics Corporation ,Us District Court ,Liquidia Corporation ,Corporate Development ,Amgen Inc ,University Of North Carolina School Medicine ,Duke University ,Chief Executive Officer ,North Carolina School ,Kryia Therapeutics ,Axsome Therapeutics ,United Therapeutics ,Sangamo Therapeutics ,Axovant Gene Therapies ,Albireo Pharma ,New York Heart Association ,Functional Class ,Dry Powder Inhalation ,Liquidia Technologies ,Private Securities Litigation Reform Act ,Liquidia Corporation Stock Exchange ,News ,Information ,Press Release ,Liquidia ,Corporation ,Nnounces ,Chief ,Executive ,Officer ,January ,022 ,Oday ,Nnounced ,Kroger ,Neffs ,Gas ,Een Lqda Us53635d2027 ,